Rep. Ted Budd Helps Introduce Bill to Reduce Reliance on China

Washington, D.C. -- Representative Ted Budd (R-NC) introduced the Protecting our Pharmaceutical Supply Chain from China Act along with Reps. Mike Gallagher (R-WI), Liz Cheney (R-WY), and Elise Stefanik (R-NY). This legislation gives companies economic incentives to manufacture pharmaceuticals and medical devices in the U.S., makes it easier to know which country a drug came from by creating a list of the country of origin of all drugs marketed in the United States, and prohibits federally qualified health facilities from purchasing pharmaceutical products from China. 

Rep. Budd said in a statement: 

“As we work together to battle the Coronavirus pandemic, we really have to start to rethink how reliant we are on China for medical supplies and pharmaceuticals. This is especially true due to China’s recent threat to cut the U.S. off from critical drugs. Given China’s recent behavior, we should do everything in our power to produce our most important pharmaceutical products and medical supplies here in America. I’m proud to help introduce a bill that accomplishes these goals.” 

Rep. Gallagher said:

“The Chinese Communist Party’s outrageous threats to withhold life saving drugs from the U.S. endangers public health and should open our eyes to our dangerous over-reliance on China in our medical supply chain. This is a national security imperative that to many Americans, is a matter of life and death. It’s past time for us to develop an aggressive plan to move critical pharmaceutical supply chains away from China.”

Rep. Cheney said:

“Relying on the Chinese Communist Party—whose lies about coronavirus created the pandemic we now face—for essential medicines is dangerous and short-sighted. As with 5G networks, when it comes to medical supply chains, national security must take precedence. China is an adversary that will use any U.S. dependence as blackmail to achieve its nefarious goals. This legislation is a critical step toward securing our supply chains and the American people.”

Rep. Stefanik said:

“China ran a disinformation campaign to cover up the coronavirus crisis for weeks, putting the rest of the world at a disadvantage in combating the spread. The time has come for Congress to take serious action to move United States pharmaceutical production out of China. We have become far too dependent on China, and it is time that we equip our domestic pharmaceutical and medical device manufacturers to be able to efficiently produce these items here in the United States. Creating this transparency in the supply chain should bring security not only to our pharmaceutical supply chain, but also to the American people who rely on their products for their own personal health needs.”

Text of the bill can be found HERE.

Stay Connected

Use the form below to sign up for my newsletter and get the latest news and updates directly to your inbox.